DEA Archived Press Releases

Press Releases before January 20, 2025
233 Results - Showing 11 to 20
PRESS RELEASE

Members of a Houston-Based Organization Responsible for Breaking Into Pharmacies in Rural Iowa and Nebraska Indicted

OMAHA, Neb – Five members of a Houston-based organization known for targeting rural pharmacies in Western Iowa and Western Nebraska face federal charges after breaking in and stealing pharmaceuticals in May and June of 2022 and 2023. These five people are part of a larger conspiracy being prosecuted out of...
PRESS RELEASE

Ohio Men Sentenced for Burglarizing Illinois and Missouri Pharmacies of Controlled Substances

EAST ST. LOUIS, Ill. – A district court judge sentenced two Columbus, Ohio, men to federal prison for burglarizing several pharmacies of oxycodone, hydrocodone and morphine pills with intent to illegally distribute the controlled substances. George H. Cunningham, 42, was sentenced to 100 months in prison and Tarvin M. Hamler...
PRESS RELEASE

Five Defendants, Including Two Doctors, Charged in Connection with Actor Matthew Perry's Fatal Overdose Death Last Year

LOS ANGELES – A licensed physician and an alleged San Fernando Valley drug dealer were arrested today in connection with the death of actor Matthew Perry, who suffered a fatal ketamine overdose in October 2023. In total, five defendants, including two doctors, have been charged in this matter, according to...
PRESS RELEASE

Jefferson County Doctor, Staffers Accused of Conspiracy, Health Care Fraud

ST. LOUIS – A doctor with an office in St. Louis and two employees have been indicted in U.S. District Court and accused of illegally prescribing controlled substances and health care fraud. Dr. David A. Parks, 66, James M. Bilderback, 58, both of Jefferson County, Missouri, and Michelle J. Scheer...
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
PRESS RELEASE

Doctor Sentenced to 10 Years in Prison for Selling Opioid Prescriptions

WICHITA, Kan. – A former Kansas physician was sentenced to 10 years in prison following a jury trial conviction and a plea agreement based on charges for selling opioid prescriptions to customers without legitimate medical need for powerful pain medications. According to court documents, Steven R. Henson, 63, of Wichita...
PRESS RELEASE

Anesthesiologist Pleads Guilty to Taking Fentanyl from Hospital

KANSAS CITY, Mo. – An anesthesiologist at a Lee’s Summit, Mo., hospital pleaded guilty in federal court today to illegally taking prescription fentanyl from the hospital. Roman Peplinski, 37, of Kansas City, Mo., waived his right to a grand jury and pleaded guilty before U.S. District Judge Greg Kays to...
PRESS RELEASE

DEA Rocky Mountain Field Division Encourages Prescription Take Back This Saturday

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...